CD8A and neoplasm: The intensity of the infiltration of the tumor stroma by CD8+/FoxP3+ lymphocytes may constitute an independent prognostic factor in the group of CRS patients with stages IIA, IIIB, and IIIC, which requires confirmation in prospective studies.